PRVA Stock Summary and Trading Ideas (Privia Health Group | NASDAQ:PRVA)

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Privia Health Group trades on the NASDAQ stock market under the symbol PRVA.

As of February 9, 2026, PRVA stock price declined to $21.45 with 70,514 million shares trading.

PRVA has a beta of 0.64, meaning it tends to be less sensitive to market movements. PRVA has a correlation of 0.12 to the broad based SPY ETF.

PRVA has a market cap of $2.64 billion. This is considered a Mid Cap stock.

Last quarter Privia Health Group reported $580 million in Revenue and $.29 earnings per share. This beat revenue expectation by $84 million and exceeded earnings estimates by $.14.

In the last 3 years, PRVA traded as high as $30.15 and as low as $15.92.

The top ETF exchange traded funds that PRVA belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.

PRVA has underperformed the market in the last year with a price return of -5.5% while the SPY ETF gained +15.3%. PRVA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.6% and -10.4%, respectively, while the SPY returned +3.5% and +0.4%, respectively.

PRVA support price is $21.42 and resistance is $22.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRVA shares will trade within this expected range on the day.